The Select Drug Program Formulary is a list for commercial members of 
medications approved by the U.S. Food
and Drug Administration that were chosen for formulary coverage based on their 
medical effectiveness, safety, and
value. The list changes periodically as the Pharmacy and Therapeutics Committee 
reviews the formulary to ensure its
continued effectiveness. The most recent changes are listed below.
Generic additions
These generic drugs recently became available in the marketplace. When these 
generic drugs became available, we
began covering them at the appropriate generic formulary level of 
cost-sharing:
Generic drug
	Brand drug
		 Formulary chapter
			Effective date
abacavir/lamivudine/zidovudine
	Trizivir
®
		 1. Antibiotics & Other Drugs Used for
		Infection
			December 23, 2013
dexmethylphenidate hcl xr 
	Focalin
TM XR
		3. Pain, Nervous System, & Psych 
			November 25, 2013
diclofenac sodium
	Solaraze
®
		9. Bone, Joint, & Muscle
			 December 2, 2013
duloxetine 
	Cymbalta
®
		 3. Pain, Nervous System, & Psych
			 December 16, 2013
fluocinonide 
	Vanos
® 
		5. Skin Medications 
			January 20, 2014
hydrocod-cpm-pseudoephedrine
	Zutripro
TM
		12. Allergy, Cough & Cold, Lung Meds
			January 20, 2014
lamivudine 
	Epivir HBV
®
		1. Antibiotics & Other Drugs Used for Infection
			January 13, 2014
lomedia 24 fe
	Not available
		10. Female, Hormone Replacement, &
		Birth Control
			January 6, 2014
moderiba*
	Ribapak
®
		1. Antibiotics & Other Drugs Used for Infection
			January 13, 2014
mycophenolic acid
	Myfortic
®
		2. Cancer & Organ Transplant Drugs
			January 13, 2014
Not available
	Klor-Con
® 25 meq Packets
		14. Vitamins & Electrolytes
			May 1, 2014
potassium citrate er 
	Urocit
®-K
		13. Urinary & Prostate Meds
			January 13, 2014
rabeprazole
	Aciphex
®
		 8. Stomach, Ulcer, & Bowel Meds
			November 18, 2013
sirolimus
	Rapamune
®
		2. Cancer & Organ Transplant Drugs
			January 20, 2014
telmisartan 
	Micardis
®
		4. Heart, Blood Pressure, & Cholesterol
			January 13, 2014
telmisartan-amlodipine
	Twynsta
®
		4. Heart, Blood Pressure, & Cholesterol
			January 13, 2014
tobramycin
	Tobi
®
		1. Antibiotics & Other Drugs Used for Infection 
			November 25, 2013
tolterodine tartrate er
	 Detrol
® LA
		13. Urinary & Prostate Meds
			January 13, 2014
			
*Generic drug requires prior authorization.
			Brand additions
			Effective May 1, 2014, these brand drugs were added to the formulary and are 
covered at the appropriate brand
			formulary level of cost-sharing:
			
Brand drug
	Formulary chapter
Asmanex
® 
	12. Allergy, Cough & Cold, Lung Meds
Ciprodex
®
	 6. Ear, Nose, Throat Medications
Estring
®
	10. Female, Hormone Replacement, & Birth Control
Tecfidera
®
	 3. Pain, Nervous System, & Psych
	
Brand deletions
	Effective July 1, 2014, these brand drugs will be covered at the appropriate 
non-formulary level of cost-sharing:
	
Brand drug
	Generic drug
		Formulary chapter
Cymbalta
®
	duloxetine
		3. Pain, Nervous System, & Psych
Epivir HBV
®
	lamivudine
		1. Antibiotics & Other Drugs Used for Infection
Rapamune
®  0.5 mg tab
	 sirolimus
		2. Cancer & Organ Transplant Drugs
Tobi
®
	 tobramycin
		1. Antibiotics & Other Drugs Used for Infection
Trizivir
®
	abacavir/lamivudine/zidovudine
		1. Antibiotics & Other Drugs Used for Infection
		
The generic drugs for the above brand drugs are available at the generic 
formulary level of cost-sharing.
		Brand deletions
		Effective July 1, 2014, these brand drugs will be covered at the appropriate 
non-formulary level of cost-sharing:
		
Brand drug
	Formulary therapeutic alternatives
		Formulary chapter
Advair
®
	Dulera
®, Symbicort
®
		12. Allergy, Cough & Cold, Lung Meds
Ciloxan
® 
	Vigamox
TM, ciprofloxacin
		11. Eye Medications
Cipro
® HC
	Ciprodex
®
		 6. Ear, Nose, Throat Medications
Flovent
® 
	Qvar
®, Asmanex
®
		12. Allergy, Cough & Cold, Lung Meds
Pulmicort Flexhaler
® 
	Qvar
®, Asmanex
®
		12. Allergy, Cough & Cold, Lung Meds
		
There are no generic equivalents for the above brand drugs; however, there 
are formulary therapeutic alternative drugs. These therapeutic alternative 
drugs are available at the appropriate formulary level of cost-sharing.